Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation
Linscott, Maryknoll P., Markus, Havell, Sennett, Mackenzie, Abendroth, Catherine, Yee, Nelson S.
Published in Biomedicines (01.08.2023)
Published in Biomedicines (01.08.2023)
Get full text
Journal Article
Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models
Linscott, Maryknoll P., Ren, Jerry R., Gestl, Shelley A., Gunther, Edward J.
Published in The American journal of pathology (01.07.2024)
Published in The American journal of pathology (01.07.2024)
Get full text
Journal Article
Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel IR-Spondin2/I RNA Fusion and INTRK3/I Mutation
Linscott, Maryknoll P, Markus, Havell, Sennett, Mackenzie, Abendroth, Catherine, Yee, Nelson S
Published in Biomedicines (01.08.2023)
Published in Biomedicines (01.08.2023)
Get full text
Journal Article
Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation
Linscott, Maryknoll P, Markus, Havell, Sennett, Mackenzie, Abendroth, Catherine, Yee, Nelson S
Published in Biomedicines (21.08.2023)
Published in Biomedicines (21.08.2023)
Get full text
Report